# Rofim

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rofim

- Industry: Hardware
- Headquarters: Marseille, France
- Website: www.rofim.fr
- Total disclosed funding: $5.1M
- Latest round: Series A (Oct 11, 2021)
- Investors on record: 4

## About

Rofim is a telemedicine company that provides innovative tele-expertise, e-RCP, and teleconsultation services to healthcare professionals, enhancing collaboration and patient care across various medical fields in Europe.Founded in 2018 by Emilie Mercadal, Rofim is based in Marseille, France. The company focuses on delivering a comprehensive telemedicine platform and has successfully completed a Series A funding round in October 2021, raising EUR 4.4 million led by Orange Ventures, with participation from Région Sud Investissement, Axeltim, and Banque des Territoires.Rofim offers a comprehensive telemedicine platform specializing in tele-expertise, e-RCP (Réunion de Concertation Pluridisciplinaire), and teleconsultation services. These core products enable healthcare professionals to collaborate efficiently, streamline patient care, and enhance access to specialized medical advice. The platform allows users to create referral channels for medical advice, monitor patients remotely, and manage complex cases through integrated medical imaging tools. Serving a diverse clientele including hospitals, clinics, general practitioners, and specialists across various medical fields, Rofim's solutions cater to the needs of healthcare organizations in markets such as France, Belgium, and other European countries. The platform has been designed to optimize workflows within healthcare settings, enhance inter-hospital collaboration, and ultimately improve patient outcomes.In 2023, Rofim reported a revenue amount of EUR 1,770,269.60 with a negative EBITDA of EUR -169,270 for 2019.Following its most recent funding round in October 2021, Rofim plans to enhance its staff and accelerate the deployment of its services within healthcare institutions and the medico-social sector. The company aims to introduce new products aimed at specific medical needs and expand its operations into additional European markets. The funding will primarily support these initiatives, ensuring that Rofim continues to adapt and grow within the rapidly evolving telemedicine landscape.

## Funding rounds

- Series A, Oct 11, 2021, $5.1M — Orange Ventures, Banque des Territoires, Région Sud Investissement, Axeltim

## Investors

- Orange Ventures — Series A
- Banque des Territoires — Series A
- Région Sud Investissement (https://capitalatlas.ai/funds/region-sud-investissement) — Series A
- Axeltim — Series A